Status:
UNKNOWN
Early Intervention in Remote Autism (IPAAD)
Lead Sponsor:
University Hospital, Brest
Conditions:
Early Intervention in Remote Autism
Eligibility:
All Genders
15-36 years
Phase:
NA
Brief Summary
The Early Start Denver Model (ESDM) has shown its efficiency in the early management of ASD. The study aims to evaluate the efficiency of a new type of management based on a semi-intensive center-bas...
Eligibility Criteria
Inclusion
- Diagnosis of ASD based on the Diagnosis and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria;
- Diagnosis of ASD on the Autism Diagnosis Observation Schedule (ADOS-2) and Autism Diagnosis Interview (ADIR) for toddlers (we will include children above or equal to 13, which is the research cut-off);
- Aged between 15 and 36 months;
- DQ of 30 or above at the MSEL
- Sign informed consent form by both parents
Exclusion
- A neurodevelopmental disorder with known etiology (e.g. fragile X syndrome, Rett syndrom)
- Significant sensory or motor impairment
- Major physical problems such as a chronic serious health condition
- History of a serious head injury and/or neurologic disease
- Seizures at time of entry
- Use of psychoactive medications (7 ) Families unavailable for the intervention and the followup over a period of 12 months
- (8) Impossibility for family to have access to the MOOC
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04660669
Start Date
December 1 2023
End Date
December 1 2025
Last Update
February 9 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
CH Réné-Dubos
Cergy-Pontoise, France
2
CHU Le Havre
Le Havre, France
3
CH Limoges
Limoges, France
4
CHU Nantes
Nantes, France